J B Chemicals & Pharmaceuticals Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

J B Chemicals & Pharmaceuticals Share Price

2,198.502.91 (0.14%)

Closed
As On: 18 Jun, 2026, 03:56 PM IST
As On: 18 Jun, 2026, 03:55 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	2,185.60
High	2,210.90
Low	2,175.70
Prev Close	2,195.60
Volume	3,40,363
VWAP(₹)	2,187.91

Key Metrics

PE Ratio(x)	49.75
EPS - TTM(₹)	44.19
MCap(₹ Cr.)	35,298.83
MCap Rank	20
PB Ratio(x)	8.48
Div Yield(%)	1.00
Face Value(₹)	1.00
52W High(₹)	2,300.00
52W Low(₹)	1,603.50
MCap/Sales	7.99
Beta(1 Month)	0.17
BV/Share(₹)	259.05

J B Chemicals share price insights

Rank 499 - ET 5002025 ranking

All Debts Paid-off
Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 15.4%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 18.63% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
J B Chemicals Share Price Update
J B Chemicals & Pharmaceuticals Ltd. share price moved up by 0.14% from its previous close of Rs 2,195.60. J B Chemicals & Pharmaceuticals Ltd. stock last traded price is 2,198.50
Share Price Value
Today/Current/Last 2,198.502,196.00
Previous Day 2,195.602,195.95

Found Insights useful?

J B Chemicals Share Price Returns

1 Day	0.14%
1 Month	3.44%
3 Months	3.8%
1 Year	27.75%
3 Years	94.79%
5 Years	187.22%

J B Chemicals Share Recommendations

Mean recosCurrent

BUY

7 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	4	4	4	4
Buy	-	-	-	1
Hold	3	3	3	4
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	7	7	7	9

Recent Recos

Target₹2225
OrganizationJM Financial
BUY

Target₹1815
OrganizationICICI Securities
ADD

Target₹2210
OrganizationJM Financial
BUY

View all Stock Recommendations

News & Analysis

View all J B Chemicals Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	916.21	1,083.00	1,100.24	1,108.49	963.96
Total Income Growth (%)	-15.40	-1.57	-0.74	14.99	-0.78
Total Expenses	780.29	814.25	819.74	835.77	769.48
Total Expenses Growth (%)	-4.17	-0.67	-1.92	8.61	2.47
EBIT	135.92	268.75	280.50	272.72	194.48
EBIT Growth (%)	-49.43	-4.19	2.85	40.23	-11.83
Profit after Tax (PAT)	101.37	197.89	207.82	202.38	145.69
PAT Growth (%)	-48.77	-4.78	2.69	38.91	-10.34
EBIT Margin (%)	14.84	24.82	25.49	24.60	20.18
Net Profit Margin (%)	11.06	18.27	18.89	18.26	15.11
Basic EPS (₹)	6.35	12.63	13.29	12.99	9.36

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	846.67	1,007.80	1,036.90	1,053.80	914.87
Total Income Growth (%)	-15.99	-2.81	-1.60	15.19	-0.63
Total Expenses	717.24	765.03	767.40	788.18	714.77
Total Expenses Growth (%)	-6.25	-0.31	-2.64	10.27	0.77
EBIT	129.43	242.77	269.50	265.62	200.10
EBIT Growth (%)	-46.69	-9.92	1.46	32.74	-5.34
Profit after Tax (PAT)	96.54	179.27	200.42	197.87	149.80
PAT Growth (%)	-46.15	-10.55	1.29	32.09	-4.21
EBIT Margin (%)	15.29	24.09	25.99	25.21	21.87
Net Profit Margin (%)	11.40	17.79	19.33	18.78	16.37
Basic EPS (₹)	6.05	11.45	12.82	12.70	9.63

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	4,207.94	3,956.31	3,521.45	3,159.22	2,463.47
Total Revenue Growth (%)	6.36	12.35	11.47	28.24	14.32
Total Expenses	3,228.42	3,068.92	2,769.94	2,603.99	1,958.57
Total Expenses Growth (%)	5.20	10.79	6.37	32.95	25.71
Profit after Tax (PAT)	709.47	659.58	552.63	409.84	385.36
PAT Growth (%)	7.56	19.35	34.84	6.35	-13.98
Operating Profit Margin (%)	23.74	22.94	22.84	18.77	21.03
Net Profit Margin (%)	17.10	16.83	15.86	13.01	15.89
Basic EPS (₹)	45.16	42.45	35.66	53.00	49.86

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	3,945.17	3,757.66	3,333.32	2,892.81	2,228.49
Total Revenue Growth (%)	4.99	12.73	15.23	29.81	11.21
Total Expenses	3,015.26	2,880.56	2,594.98	2,365.77	1,757.20
Total Expenses Growth (%)	4.68	11.01	9.69	34.63	24.61
Profit after Tax (PAT)	674.10	652.54	543.36	388.89	361.00
PAT Growth (%)	3.30	20.09	39.72	7.72	-19.25
Operating Profit Margin (%)	24.02	23.80	23.61	19.46	21.74
Net Profit Margin (%)	17.32	17.52	16.47	13.48	16.48
Basic EPS (₹)	42.91	42.00	35.07	50.29	46.71

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue decline of 15.4%, which is lowest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 18.63% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	4,968.65	4,273.78	3,994.13	3,553.87	2,607.40
Total Assets Growth (%)	16.26	7.00	12.39	36.30	16.50
Total Liabilities	809.43	840.46	1,070.80	1,073.52	468.79
Total Liabilities Growth (%)	-3.69	-21.51	-0.25	129.00	10.39
Total Equity	4,159.22	3,433.32	2,923.33	2,480.35	2,138.61
Total Equity Growth (%)	21.14	17.45	17.86	15.98	17.93
Current Ratio (x)	4.92	3.04	2.13	2.76	3.32
Total Debt to Equity (x)	0.00	0.00	0.12	0.22	0.01
Contingent Liabilities	1,237.97	1,165.42	1,110.90	148.86	68.13

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	4,823.50	4,177.90	3,913.64	3,470.15	2,538.07
Total Assets Growth (%)	15.45	6.75	12.78	36.72	15.34
Total Liabilities	785.79	800.70	1,027.38	1,027.67	434.40
Total Liabilities Growth (%)	-1.86	-22.06	-0.03	136.57	10.26
Total Equity	4,037.71	3,377.19	2,886.26	2,442.48	2,103.67
Total Equity Growth (%)	19.56	17.01	18.17	16.11	16.45
Current Ratio (x)	4.84	3.04	2.09	2.75	3.32
Total Debt to Equity (x)	0.00	0.00	0.12	0.22	0.01
Contingent Liabilities	1,237.97	1,165.42	1,110.90	148.86	68.13

All figures in Rs Cr, unless mentioned otherwise

Insights

All Debts Paid-off
Company has become debt free for the first time since last 5 years. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	-703.92	902.45	800.61	625.61	170.13
Net Cash used in Investing Activities	585.88	-295.90	-403.83	-961.79	2.32
Net Cash flow from Financing Activities	123.10	-579.67	-385.49	356.54	-138.39
Net Cash Flow	4.91	26.88	11.28	20.39	34.07
Closing Cash & Cash Equivalent	115.09	115.09	88.22	76.93	56.54
Closing Cash & Cash Equivalent Growth (%)	0.00	30.47	14.66	36.06	151.60
Total Debt/ CFO (x)	0.00	0.02	0.45	0.88	0.15

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	644.89	884.03	789.03	628.64	147.10
Net Cash used in Investing Activities	-587.21	-289.93	-412.45	-955.88	4.18
Net Cash flow from Financing Activities	-107.68	-574.27	-374.08	343.41	-137.85
Net Cash Flow	-49.85	19.84	2.49	16.20	13.42
Closing Cash & Cash Equivalent	26.36	76.21	56.37	53.88	37.69
Closing Cash & Cash Equivalent Growth (%)	-65.41	35.19	4.62	42.98	55.33
Total Debt/ CFO (x)	0.00	0.00	0.43	0.84	0.18

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	17.05	19.21	18.90	16.52	18.05
Return on Capital Employed (%)	22.50	24.69	25.45	19.71	22.93
Return on Assets (%)	14.27	15.43	13.83	11.53	14.77
Interest Coverage Ratio (x)	209.69	91.24	21.07	19.57	113.79
Asset Turnover Ratio (x)	0.90	0.95	0.92	1.02	0.92
Price to Earnings (x)	46.73	38.31	46.51	37.31	31.65
Price to Book (x)	7.96	7.36	8.76	6.15	5.70
EV/EBITDA (x)	28.25	23.49	27.68	22.28	20.84
EBITDA Margin (%)	28.14	27.31	26.81	22.40	24.03

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	16.69	19.32	18.82	15.92	17.16
Return on Capital Employed (%)	21.92	24.66	25.18	18.95	21.73
Return on Assets (%)	13.97	15.61	13.88	11.20	14.22
Interest Coverage Ratio (x)	242.20	115.45	22.56	19.63	110.64
Asset Turnover Ratio (x)	0.86	0.92	0.89	0.96	0.92
Price to Earnings (x)	49.26	38.76	47.17	39.22	33.78
Price to Book (x)	8.20	7.48	8.87	6.24	5.79
EV/EBITDA (x)	29.76	23.90	28.31	23.35	22.21
EBITDA Margin (%)	28.56	28.27	27.71	23.34	25.00

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
46%
Positive Movement
since 1st Jan 2005
on basis
54%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 2206.70 Pivot
2193.40
S1 2182.30
R2 2217.80 S2 2169.00
R3 2242.20 S3 2144.60
Average True Range
5 Days 14 Days 28 Days
52.57 57.85 56.70

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
J B Chemicals	49.75	8.49	17.05	22.50	14.27	9.92	23.74	17.10	45.16	4.92	0.00	0.00
Anthem Biosciences Ltd.	75.75	14.74	19.45	27.56	17.25	25.92	40.27	27.85	10.55	5.54	0.02	0.06
Ipca Labs	34.32	4.11	14.15	17.23	9.22	15.36	17.98	12.35	46.94	2.76	0.09	0.62
Ajanta Pharma	36.36	8.48	23.32	29.40	17.15	13.41	25.56	19.36	84.53	2.64	0.05	0.40
Gland Pharma	35.32	3.50	9.91	13.96	8.21	20.18	23.67	15.97	62.35	4.68	0.02	0.24
Add More

Annual Ratios (%)

Choose from Peers

Emcure Pharmaceuticals Ltd.
Wockhardt
Sai Life Science Ltd.
Neuland Labs
Rubicon Research Ltd.

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Found Peer Comparison useful?

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 7,83,57,892 48.80 % 1.25
Pledge 0 0.00 % 0.00
FII 2,62,26,011 16.33 % 1.44
DII 3,43,23,740 21.38 % -1.97
MF 3,04,99,962 19.00 % -0.60
Others 2,16,51,063 13.49 % -0.72
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 48.80 47.55 47.56 47.73
Pledge 0.00 0.00 0.00 0.00
FII 16.33 14.88 15.30 17.77
DII 21.38 23.35 22.83 19.62
Mutual Funds 19.00 19.61 19.15 16.27
Others 13.49 14.21 14.31 14.87

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Kotak Midcap Direct-G
Equity: Mid Cap
3
- 1,044.01
  Amount Invested (in Cr.)
- 1.61238513%
  % of AUM
- 0.00
  % Change (MoM basis)
Axis Small Cap Direct-G
Equity: Small Cap
4
- 646.92
  Amount Invested (in Cr.)
- 2.32370849%
  % of AUM
- 0.00
  % Change (MoM basis)
Canara Robeco Small Cap Direct-G
Equity: Small Cap
3
- 293.42
  Amount Invested (in Cr.)
- 2.2%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

J B Chemicals Top Searches

Corporate Actions

Recent
General Meeting
-
May 25, 2026
Final
930%
May 11, 2026
Board Meeting
Audited Results & Final Dividend
May 05, 2026

Announced on	Meeting on
May 05, 2026	May 11, 2026
Audited Results & Final Dividend
Feb 02, 2026	Feb 05, 2026
Interim Dividend
Dec 29, 2025	Jan 16, 2026
Quarterly Results
Oct 24, 2025	Nov 11, 2025
Quarterly Results
Jul 21, 2025	Jul 30, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 11, 2026 May 29, 2026 930%
Feb 05, 2026 Feb 11, 2026 1270%
May 14, 2025 Jul 30, 2025 700%
Feb 05, 2025 Feb 07, 2025 850%
May 17, 2024 Aug 14, 2024 675%
Bonus
Announced on Ex-Date
Aug 29, 1998 Oct 05, 1998
Bonus Ratio: 1 share(s) for every 1 shares held
Sep 30, 1993 Oct 01, 1993
Bonus Ratio: 1 share(s) for every 2 shares held
Splits
Announced on Ex-Date
May 24, 2023 Sep 18, 2023
Split: Old FV2.0| New FV:1.0
Jan 27, 2005 Apr 05, 2005
Split: Old FV10.0| New FV:2.0
Rights
Announced on Ex-Date
Dec 07, 1996 Jun 10, 1996
Rights ratio: 1 share for every 5 held at a price of Rs 80.0
AGM/EGM Meetings
Announced on Meeting on
May 25, 2026 Jun 17, 2026
-
Mar 30, 2026 Apr 28, 2026
-
Feb 23, 2026 Mar 25, 2026
-
Jul 11, 2025 Aug 06, 2025
-
Jul 26, 2024 Aug 21, 2024
-

About J B Chemicals

J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 35,298.83 Crore) operating in Pharmaceuticals sector.

J B Chemicals & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2026.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 916.21 Crore, down 15.40 % from last quarter Total Income of Rs 1,083.00 Crore and down 4.95 % from last year same quarter Total Income of Rs 963.96 Crore. Company has reported net profit after tax of Rs 101.37 Crore in latest quarter.

The company’s top management includes Mr.Arun Duggal, Mr.Aman Mehta, Mr.Amal Kelshikar, Mr.Hasmukh Patel, Mr.Sudhir Menon, Mr.Ashwani Kumar Puri, Ms.Richa Arora, Mr.Sumit Bose, Mr.Kaushal Singh Solanki, Mr.Sandeep Phadnis. Company has D N V & Co. as its auditors. As on 31-03-2026, the company has a total of 16.06 Crore shares outstanding.

J B Chemicals Share Price Today is Rs. 2198.50. On previous day, the J B Chemicals Share Price (NSE) closed at Rs. 2192.8, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 48.8% of the stake in J B Chemicals shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of J B Chemicals stocks was 16.33% as compared to 14.88% in Dec 2025 with increase of 1.45%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 21.38% as compared to 23.35% in Dec 2025 with decrease of 1.97%. Out of the total DII holdings in J B Chemicals shares 19.0% was held by mutual funds. The rest including public held is 13.49%. J B Chemicals stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
J B Chemicals Dividend: Ever since 1976, J B Chemicals dividends has been paid out around 48 times. As on 18 Jun, 2026, 03:56 PM IST, The overall dividend yield for J B Chemicals stands at 1.0%. The last dividend paid was on May 29, 2026 (Rs. 9.3). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 44.19.

J B Chemicals Bonus: The most recent bonus issue had been in year October 5, 1998 around 27 years ago at 1 : 1 ratio. The first bonus issue was announced in Sep 1993.

Stock Forecast:
After showing 916.21 Cr. of sales and 15.4% of quarterly net loss, there have been multiple ups and downs in the J B Chemicals stock prices in the past few weeks. For example, J B Chemicals stock price on 10th of June 2026 was around Rs. 2201.5. J B Chemicals share price now stands at an average of Rs. 2198.50. Judging by last week's performance, stock is in down trend.

J B Chemicals has a median target price of Rs. 2060.5 in 12 months by 10 analysts. They have provided a high estimate of Rs. 2400.0 and low estimate of Rs. 1752.0 for J B Chemicals share.

Historical Prices and Performance:
J B Chemicals, incorporated in 1976 is a Mid Cap company (with a market cap of Rs. 35252.27) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by J B Chemicals stock was 17.05%, 19.21%, 18.9%, 16.52% and 18.05% respectively.
The J B Chemicals share gave a 3 year return of 94.53% as compared to Nifty 50 which gave a return of 27.94%.
J B Chemicals announced 930.0% final dividend on May 29, 2026.

Key Metrics:
PE Ratio of J B Chemicals is 49.69
Prices/Sales Ratio of J B Chemicals is 7.99
Price/Book Ratio of J B Chemicals is 8.48

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For J B Chemicals, major competitors and peers include Anthem Biosciences Ltd., Ipca Labs, Ajanta Pharma and Gland Pharma. As of Dec 2025, the dividend yield of J B Chemicals stands at 1.0% while Anthem Biosciences Ltd., Ipca Labs, Ajanta Pharma and Gland Pharma stand at 0.0%, 0.39%, 0.91% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 49.69 and 8.48 respectively.

Leadership of J B Chemicals :
Sandeep Phadnis is Co. Secretary & Compl. Officer
Kaushal Singh Solanki is Chief Financial Officer
Arun Duggal is Chairman & Ind.Director
Aman Mehta is Managing Director
Ashwani Kumar Puri is Independent Director
Sumit Bose is Independent Director
Richa Arora is Independent Director
Amal Kelshikar is Non Executive Director
Hasmukh Patel is Non Executive Director
Sudhir Menon is Non Executive Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

Nifty Smallcap 100, Nifty 500, BSE 500, Nifty Pharma, BSE 250 SmallCap Index

Address

302 , Iscon Mall ,Star India Bazaar Building,Opp Jodhpur BRTS Satellite,Ahmedabad, Gujarat - 380015

Contact

secretarial@jbpharma.com

https://www.jbpharma.com

Executive Leadership

AD

Arun Duggal

Chairman & Ind.Director

AM

Aman Mehta

Managing Director

AK

Amal Kelshikar

Non Executive Director

HP

Hasmukh Patel

Non Executive Director

Show More

Auditors

Deloitte Haskins & Sells LLP

D N V & Co.

FAQs about J B Chemicals share

1. What is J B Chemicals share price and what are the returns for J B Chemicals share?
J B Chemicals share price is Rs 2,198.50 as on 18 Jun, 2026, 03:56 PM IST. J B Chemicals share price is up by 0.14% based on previous share price of Rs 2,192.8. J B Chemicals share price trend:
- Last 12 Months: J B Chemicals share price moved up 27.75%
- Last 3 Years: J B Chemicals Share price moved up by 94.79%
2. What has been highest price of J B Chemicals share in last 52 weeks?
52 Week high of J B Chemicals share is Rs 2,300.00 while 52 week low is Rs 1,603.50
3. What are the returns for J B Chemicals share?
Return Performance of J B Chemicals Shares:
- 1 Week: J B Chemicals share price moved down by 2.41%
4. What is the market cap of J B Chemicals?
Within the Pharmaceuticals sector, J B Chemicals stock has a market cap rank of 20. J B Chemicals has a market cap of Rs 35,298.83 Cr.
5. What is the PE & PB ratio of J B Chemicals?
The PE ratio of J B Chemicals stands at 49.69, while the PB ratio is 8.48.

Top Gainers

As on 03:59 PM | 18 Jun 2026

789.90

111.40 (16.42%)

1,186.40

143.16 (13.73%)

163.00

16.35 (11.15%)

271.95

23.03 (9.26%)

New India Assurance

178.67

13.21 (7.99%)

Top Losers

As on 03:59 PM | 18 Jun 2026

82.31

-7.76 (-8.62%)

84.62

-5.74 (-6.36%)

1,812.40

-102.70 (-5.37%)

535.00

-23.65 (-4.24%)

1,119.40

-45.70 (-3.93%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.